Enoximone
Back to searchMolecule Structure
Scientific Name
Enoximone
Description of the Drug
Enoximone is a selective phosphodiesterase inhibitor indicated in the short term treatment of congestive heart failure.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB04880
http://www.drugbank.ca/drugs/DB04880
Brand Name(s)
Perfan
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Phosphodiesterase 3 | PROTEIN FAMILY | INHIBITOR | CHEMBL2094125 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL44049 |
| PharmGKB | PA164768794 |
| Human Metabolome Database | HMDB0015599 |
| DrugBank | DB04880 |
| PubChem: Thomson Pharma | 14749775 |
| PubChem | 53708 |
| Nikkaji | J22.780C |
| BindingDB | 50241379 |
| EPA CompTox Dashboard | DTXSID8045147 |
| DrugCentral | 1014 |
| ChemicalBook | CB2682723 |
| Guide to Pharmacology | 9063 |
| rxnorm | ENOXIMONE |
| PubChem: Drugs of the Future | 12012687 |
| ChEBI | 135010 |
| ZINC | ZINC000009225358 |
